Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gini F Fleming

Showing results (51-60 of 180) with videos related to

Pageof 18
Sort By:
Oncoimmunology|October 10, 2015
Characterization of T cell repertoire of blood, tumor, and ascites in ovarian cancer patients using next generation sequencingMiran Jang, Poh-Yin Yew, Kosei Hasegawa, et al.
Cancer Chemotherapy and Pharmacology|July 6, 2004
A phase I trial of pharmacokinetic modulation of carboxyamidotriazole (CAI) with ketoconazole in patients with advanced cancerApurva A Desai, Federico Innocenti, Linda Janisch, et al.
Gynecologic Oncology|December 1, 2009
The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group studyJohn K Chan, Chunqiao Tian, Gini F Fleming, et al.
Gynecologic Oncology|September 5, 2025
Race and neighborhood disadvantage in patients with stage I-III endometrioid endometrial carcinoma treated at a tertiary referral centerSarah A Ackroyd, Gabrielle Sudilovsky, Yan Che, et al.
Research Square|August 23, 2023
Stress, Isolation, and Sleep Quality among Breast Cancer Survivors throughout the COVID-19 Pandemic: A Longitudinal Study in a Multi-Ethnic CohortFangyuan Zhao, Jincong Q Freeman, Nora Jaskowiak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
Administration of glucocorticoids to ovarian cancer patients is associated with expression of the anti-apoptotic genes SGK1 and MKP1/DUSP1 in ovarian tissuesAmal Melhem, S Diane Yamada, Gini F Fleming, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 9, 2024
Evaluation of cyclin-dependent kinase 4/6 inhibitor-induced serum creatinine elevations in patients with hormone receptor positive breast cancerEmily Ly, Frederick M Howard, Nan Chen, et al.
Gynecologic Oncology|June 28, 2015
Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinomaErica M Stringer-Reasor, Gabrielle M Baker, Maxwell N Skor, et al.
Stress and Health : Journal of the International Society for the Investigation of Stress|June 18, 2025
Longitudinal Changes in Stress and Isolation Among Multi-Ethnic Breast Cancer Survivors Throughout COVID-19Fangyuan Zhao, Jincong Q Freeman, Nora Jaskowiak, et al.
Endocrinology|February 24, 2026
Ovarian cancer cell glucocorticoid receptor activation increases myeloid-derived suppressor cell tumor infiltrationManisha Taya, Eleanore Gray, Tryambak Srivastava, et al.
Pageof 18

Showing results (51-60 of 180) with videos related to

Sort By:
Pageof 18
Oncoimmunology|October 10, 2015
Characterization of T cell repertoire of blood, tumor, and ascites in ovarian cancer patients using next generation sequencingMiran Jang, Poh-Yin Yew, Kosei Hasegawa, et al.
Cancer Chemotherapy and Pharmacology|July 6, 2004
A phase I trial of pharmacokinetic modulation of carboxyamidotriazole (CAI) with ketoconazole in patients with advanced cancerApurva A Desai, Federico Innocenti, Linda Janisch, et al.
Gynecologic Oncology|December 1, 2009
The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group studyJohn K Chan, Chunqiao Tian, Gini F Fleming, et al.
Gynecologic Oncology|September 5, 2025
Race and neighborhood disadvantage in patients with stage I-III endometrioid endometrial carcinoma treated at a tertiary referral centerSarah A Ackroyd, Gabrielle Sudilovsky, Yan Che, et al.
Research Square|August 23, 2023
Stress, Isolation, and Sleep Quality among Breast Cancer Survivors throughout the COVID-19 Pandemic: A Longitudinal Study in a Multi-Ethnic CohortFangyuan Zhao, Jincong Q Freeman, Nora Jaskowiak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
Administration of glucocorticoids to ovarian cancer patients is associated with expression of the anti-apoptotic genes SGK1 and MKP1/DUSP1 in ovarian tissuesAmal Melhem, S Diane Yamada, Gini F Fleming, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 9, 2024
Evaluation of cyclin-dependent kinase 4/6 inhibitor-induced serum creatinine elevations in patients with hormone receptor positive breast cancerEmily Ly, Frederick M Howard, Nan Chen, et al.
Gynecologic Oncology|June 28, 2015
Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinomaErica M Stringer-Reasor, Gabrielle M Baker, Maxwell N Skor, et al.
Stress and Health : Journal of the International Society for the Investigation of Stress|June 18, 2025
Longitudinal Changes in Stress and Isolation Among Multi-Ethnic Breast Cancer Survivors Throughout COVID-19Fangyuan Zhao, Jincong Q Freeman, Nora Jaskowiak, et al.
Endocrinology|February 24, 2026
Ovarian cancer cell glucocorticoid receptor activation increases myeloid-derived suppressor cell tumor infiltrationManisha Taya, Eleanore Gray, Tryambak Srivastava, et al.
Pageof 18